Due to the scarcity of genuine GLP-1 receptor agonists used for type 2 diabetes and weight control, a rising number of people are accidentally taking counterfeit versions, potentially endangering their health
Call (310) 888-8087 or request an appointment through the online contact form.
Primary candidates include patients with type 2 diabetes and established cardiovascular disease, those with multiple cardiovascular risk factors including dyslipidemia, and adults with obesity or overweight with weight-related comorbidities
However, some more serious risks are non-arteritic anterior ischemic optic neuropathy, a form of permanent eye stroke, and diabetic retinopathy, a worsening of existing diabetic eye disease
The use of technology in healthcare, such as dosage calculators, reflects a broader trend towards data-driven medicine, where decisions are informed by evidence and tailored to individual circumstances
Avoid repeated freeze-thaw cycles, which degrade peptide structural integrity